In a speech at the Chief Executives Club of Boston, Eli Lilly and Company (NYSE: LLY) chairman and chief executive officer, Sidney Taurel, predicted that the coming biomedical revolution will move medicine from its current state of treating symptoms to predicting and preventing diseases.
A new photographic exhibit, called ?The Image of MS? has been unveiled at the Ara Pacis Museum in Rome to dispel myths about multiple sclerosis (MS), challenge public perceptions about the disease, and encourage those with symptoms to seek treatment as early as possible.
World diabetes leaders left the Global Changing Diabetes Leadership Forum, which took place in New York City on 13?14 March 2007, with a sense of activism to return home to start changing diabetes.
Reductions in the death rate from homicide, HIV disease, unintentional injuries – and among women, heart disease – have contributed to narrowing the life expectancy gap between blacks and whites in the United States, although substantial inequalities and challenges remain, according to a study in the March 21 issue of JAMA.
Patients with moderate to severe sleep apnea who have significantly higher serum levels of inflammatory markers that serve as precursors to coronary artery disease, as well as lesions associated with silent brain infarction, have an elevated risk of stroke, according to a group of Japanese medical researchers.
Patients in Liverpool are to trial a new therapy for pancreatic cancer — a disease which sees most sufferers die within a year of diagnosis.
A small but telling study from the Johns Hopkins Children?s Center reveals an ominous trend: more than expected, obesity shadows Baltimore?s homeless children and their caregivers, putting them at high risk for heart disease, stroke and type 2 diabetes, among other conditions.
The U.S. Food and Drug Administration (FDA) has requested that all manufacturers of sedative-hypnotic drug products, a class of drugs used to induce and/or maintain sleep, strengthen their product labeling to include stronger language concerning potential risks.
Uncontrolled neuronal death in the brain often gives rise to neurodegenerative illnesses like Parkinson or Alzheimer disease. Whether or not neurons have a long and healthy life is, apart from other factors, determined by the presence of neurotrophic factors. Scientists of the Max Planck Institute of Neurobiology have now provided unambiguous proof that the presence of the neurotrophic factor GDNF and its receptor Ret are essential for the survival of neurons in a specific brain region.
Periodontal diseases may contribute to the progression to pre-diabetes, according to a new study that appears in the March issue of the Journal of Periodontology.